Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression
Details
Location:
EU 27
Funding agency:
Contracting Authority Type:
Development Institution
Status:
Closed
Budget:
Euro 60,000,000
Award ceiling:
N/A
Award floor:
N/A
Sector:
Health, Information & Communication Technology
Eligible applicants:
Unrestricted / Unspecified, Individuals
Eligible nationalities:
Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Argentina, Armenia, Aruba, Austria, Azerbaijan, Azores, Bangladesh, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, British Virgin Islands, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canary Islands, Cape Verde, Caribbean Netherlands, Cayman Islands, Central African Republic, Chad, Chile, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Dem. Rep. Congo, Denmark, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Eswatini (Swaziland), Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, Nicaragua, Niger, Nigeria, North Korea, North Macedonia, Norway, Pakistan, Palau, Palestine / West Bank & Gaza, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Romania, Rwanda, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Seychelles, Sierra Leone, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, St. Pierre and Miquelon, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Turkmenistan, Turks and Caicos, Tuvalu, Uganda, Ukraine, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted:
29 Jun, 2021
Description
Horizon Europe is the EU's new €95.5 billion research and development program that spans practically every industry and profession, from pharmaceuticals to philosophy. Thanks to considerable lobbying, it will subsidize innovation in numerous sectors in the EU.
Horizon Europe’s program entitled “Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression” aims to bring results that are oriented, tailored towards, and contribute to the outcomes listed below:
• Clinicians, medical professionals, and people have access to and employ validated artificial intelligence (AI) techniques for disease risk assessment leading to citizens being better equipped to manage their own health.
• Health care experts use AI technologies that are robust, trustworthy, and able to maintain privacy to evaluate and predict the risk for and/or progression of chronic noncommunicable diseases thereby benefitting citizens with better health outcomes.
• Health care experts devise evidence-based recommendations and guidelines for AI-based personalized preventative initiatives leading to citizens benefitting from improved healthcare measures that are above those offered by standard care.
• Quantitative indicators are used by health care professionals to recognize and follow up those people who are at a high risk of developing and/or progressing chronic noncommunicable diseases.
The planned opening date is October 6, 2021.
The deadlines are February 1, 2022, 17:00:00 Brussels time, and September 6, 2022, 17:00:00 Brussels time.